XTRA:FMEHealthcare
Assessing Fresenius Medical Care (XTRA:FME) Valuation As Earnings Approach And Korea MOU Builds Interest
Investor focus around Fresenius Medical Care (XTRA:FME) is building ahead of its 24 February 2026 earnings release, as the market weighs revenue, margin and regional performance alongside the recent MOU in Korea on high-volume hemodiafiltration.
See our latest analysis for Fresenius Medical Care.
Recent momentum has been mixed, with a 1 month share price return of 11.20% and a year to date share price return of 3.04%, set against a 1 year total shareholder return decline of 4.60%. This...